SAN JOSE, Calif., Aug. 24 /PRNewswire-FirstCall/ -- VNUS(R) Medical Technologies, Inc. , a worldwide leader in medical devices for the minimally invasive treatment of venous reflux disease, today announced its plans to present at the Roth Capital Partners 5th Annual New York Conference, to be held September 5-6, 2007, at the Westin New York at Times Square, New York City.
VNUS’ presentation is currently scheduled for 11:30 a.m. ET on Thursday, September 6, and will be webcast on the corporate website at http://ir.vnus.com/medialist.cfm. The management speakers will be President and Chief Executive Officer Brian Farley and Vice President, Finance and Administration and Chief Financial Officer Tim Marcotte.
About VNUS Medical Technologies, Inc.
Founded in 1995 and headquartered in San Jose, California, VNUS Medical Technologies is a worldwide leader in medical devices for the minimally invasive treatment of venous reflux disease, a progressive condition that causes the varicose veins afflicting 25 million Americans. The pioneering company in the field, VNUS now offers the ClosureFAST system, which consists of a proprietary radiofrequency (RF) generator and proprietary disposable endovenous catheters and devices to close diseased veins through the application of temperature-controlled RF energy. VNUS devices have been used in more than 200,000 procedures worldwide. For more information, please visit http://www.vnus.com.
VNUS(R) Medical Technologies, Inc.
CONTACT: Tim Marcotte, Vice President, Finance and Administration, ChiefFinancial Officer of VNUS Medical Technologies, Inc., +1-408-473-1199,ir@vnus.com
Web site: http://www.vnus.com/
